Gabriel Monteiro Arnozo

Gabriel Monteiro Arnozo

Auto-generated profile, based on publicly available information

Gabriel Monteiro Arnozo

Universidade Federal de Alagoas

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2020 in Wiener klinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
RMRodrigo da Rosa Mesquita
Rodrigo da Rosa Mesquita
LJLuiz Carlos Francelino Silva Junior
Luiz Carlos Francelino Silva Junior
FSFernanda Mayara Santos Santana
Fernanda Mayara Santos Santana
TOTatiana Farias de Oliveira
Tatiana Farias de Oliveira
RARafaela Campos Alcântara
Rafaela Campos Alcântara
CSCarlos Dornels Freire De Dornels Freire de Souza
Carlos Dornels Freire De Dornels Freire de Souza

1 January 2021 in Brazilian Journal of Cardiovascular Surgery
Verified
Journal Article
Open access
TOTatiana Farias de Oliveira
Tatiana Farias de Oliveira
CRCarlos Alberto de Oliveira Rocha
Carlos Alberto de Oliveira Rocha
ASAisla Graciele Galdino dos Santos
Aisla Graciele Galdino dos Santos
LJLuiz Carlos Francelino Silva Junior
Luiz Carlos Francelino Silva Junior
SASaulo Henrique Salgueiro de Aquino
Saulo Henrique Salgueiro de Aquino
CSCarlos Dornels Freire De Dornels Freire de Souza
Carlos Dornels Freire De Dornels Freire de Souza
The present study intends to systematically review the literature on the use of extracorporeal membrane oxygenation (ECMO) in patients with coronavirus disease 2019 (COVID-19). The research was carried out according to the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyzes (PRISMA). Studies were selected from PubMed/MEDLINE and LILACS databases between December 2019 and May 17 2020, using the descriptors "ECMO AND COVID-19", "Extracorporeal Membrane Oxygenation AND COVID-19", "ECLS AND COVID-19", and "Extracorporeal Life Support AND COVID-19". Exclusion criteria were government epidemiological bulletins, comments, literature reviews, and articles without full access to content. Two hundred and thirty-three scientific productions were found, however only 18 did not met the exclusion criteria and could be included in this study, amouting to a total of 911 patients - 624 (68.5%) men, 261 (28.6%) women, and 26 (2.8%) without sex information. The mean age of the patients was 53.7 years. ECMO was necessary in 274 (30.1%) people (200 [73%] submitted to venovenous ECMO, nine [3.3%] to veno-arterial ECMO, and seven [2.5%] moved between these two types or needed a more specific ECMO according to the disease prognosis). Five studies did not specify the type of ECMO used, amounting 57 (20.8%) patients. Five patients (1.8%) were discharged, 77 (28.1%) died, 125 (45.6%) remained hospitalized until publication time of their respective studies, and 67 patients (24.4%) had no outcome information. It is evident that more research, covering larger populations, must be carried out in order to clearly elucidate the role of ECMO in the treatment of COVID-19.

1 July 2020 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
CSCarlos Dornels Freire De Dornels Freire de Souza
Carlos Dornels Freire De Dornels Freire de Souza
ASAisla Graciele Galdino dos Santos
Aisla Graciele Galdino dos Santos
ECEuclides José Oliveira da Cunha
Euclides José Oliveira da Cunha
TOTatiana Farias de Oliveira
Tatiana Farias de Oliveira
SASaulo Henrique Salgueiro de Aquino
Saulo Henrique Salgueiro de Aquino
EFEtvaldo Rodrigues da Silva Filho
Etvaldo Rodrigues da Silva Filho
Covid-19 was recorded for the first time in Wuhan, the capital of the Hubei province, in China, in December 2019. The disease is caused by a new coronavirus (Sars-COV-2) and transmitted by the sharing of aerosols1 . From its origin until the 21st of April of 2020, the disease had already caused the death of more than 175,000 people worldwide. There had been more than 2.5 million confirmed cases on this date2 .

1 January 2021 in Revista Portal: Saúde e Sociedade
Verified
Journal Article
Open access
PDF file
LJLuiz Carlos Francelino Silva Junior
Luiz Carlos Francelino Silva Junior
GSGibson Santana
Gibson Santana
RMRodrigo Mesquita
Rodrigo Mesquita
TOTatiana Oliveira
Tatiana Oliveira
GAGabriel Arnozo
Gabriel Arnozo
RARafaela Alcântara
Rafaela Alcântara
Background: COVID-19 is a respiratory disease that appeared in China in late 2019 and soon spread around the world, causing a pandemic. Aims: This is study sought to systematize information about life habits in epidemiological studies in patients with COVID-19. Methods: This is a systematic review conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyzes (PRISMA) recommendations. We selected articles published in PubMed, Medline and Scopus database between January 1 and April 24, 2020, using the descriptors COVID-19, SARS-CoV-2, 2019-nCoV, n-CoV and coronavirus combined with clinical profile and epidemiology. In this study, we sought to identify characteristics about patients' lifestyle habits: smoking (current or previous), alcohol consumption and physical activity. Results: We analyzed 7489 scientific studies, of which 158 had clinical and epidemiological variables, amounting 100.0563 patients. 30 studies included lifestyle habits (8,323 individuals) from five countries: Brazil, China, Korea, Spain and USA (593). A percentage of 56.5% (n = 4624) were men and 44.4% (n = 3687) women. Among the variables, smoking (current or previous) was present in 30 investigations; alcohol consumption in four and physical activity was not observed in any article. The highest smoking rates were observed in the USA (21.79%) and Spain (18.75%). Alcohol consumption was 7.73%. Being higher in Brazil (17.28%). Conclusions: New studies on the epidemiological and clinical aspects of COVID-19 include variables about lifestyle, especially smoking, alcohol consumption and physical activity. This information may offer future knowledge about the factors of illness and severity of COVID-19 in the population. Keywords: Risk factors. Coronavirus infection. Systematic review.